mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.12 |
0.7 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.7 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |